$BNET
BION ENVIRONMENTAL TECHNOLOGIES INC Stock $bnet

$bnet Overview Financials Valuation SEC Filings Company Website

2024 Q4 Form 10-Q Financial Statement

#000107997324001553 Filed on November 14, 2024

Income Statement

Concept	2024 Q4	2024 Q3
Revenue
YoY Change
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin
YoY Change
% of Gross Profit
Research & Development		$6.374K
YoY Change		-23.2%
% of Gross Profit
Depreciation & Amortization		$285.00
YoY Change		-38.18%
% of Gross Profit
Operating Expenses		$966.1K
YoY Change		43.12%
Operating Profit		-$966.1K
YoY Change		43.12%
Interest Expense
YoY Change
% of Operating Profit
Other Income/Expense, Net		-$205.6K
YoY Change		191.46%
Pretax Income
YoY Change
Income Tax
% Of Pretax Income
Net Earnings		-$1.172M
YoY Change		57.15%
Net Earnings / Revenue
Basic Earnings Per Share		-$0.02
Diluted Earnings Per Share		-$0.02
COMMON SHARES
Basic Shares Outstanding	56.53M shares	56.53M shares
Diluted Shares Outstanding		56.53M shares

Balance Sheet

Concept	2024 Q4	2024 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments
YoY Change
Cash & Equivalents		$35.97K
Short-Term Investments
Other Short-Term Assets
YoY Change
Inventory
Prepaid Expenses		$61.35K
Receivables
Other Receivables
Total Short-Term Assets		$103.3K
YoY Change		-36.47%
LONG-TERM ASSETS
Property, Plant & Equipment		$410.00
YoY Change		-99.99%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets		$21.64K
YoY Change		-99.72%
TOTAL ASSETS
Total Short-Term Assets		$103.3K
Total Long-Term Assets		$21.64K
Total Assets		$125.0K
YoY Change		-98.41%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable
YoY Change
Accrued Expenses
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities		$6.095M
YoY Change		152.03%
LONG-TERM LIABILITIES
Long-Term Debt
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities		$6.095M
Total Long-Term Liabilities
Total Liabilities		$6.222M
YoY Change		51.2%
SHAREHOLDERS EQUITY
Retained Earnings		-$140.1M
YoY Change		9.47%
Common Stock		$0.00
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity		-$6.135M
YoY Change
Total Liabilities & Shareholders Equity		$125.0K
YoY Change		-98.41%

Cashflow Statement

Concept	2024 Q4	2024 Q3
OPERATING ACTIVITIES
Net Income		-$1.172M
YoY Change		57.15%
Depreciation, Depletion And Amortization		$285.00
YoY Change		-38.18%
Cash From Operating Activities		-$217.8K
YoY Change		-44.92%
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities		$201.6K
YoY Change		171.5%
NET CHANGE
Cash From Operating Activities		-$217.8K
Cash From Investing Activities
Cash From Financing Activities		$201.6K
Net Change In Cash		-$16.24K
YoY Change		-96.66%
FREE CASH FLOW
Cash From Operating Activities		-$217.8K
Capital Expenditures
Free Cash Flow		-$217.8K
YoY Change		-61.1%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2024Q3	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2025
CY2024Q3	dei	Entity Central Index Key EntityCentralIndexKey	0000875729
CY2024Q3	dei	Document Type DocumentType	10-Q
CY2024Q3	dei	Document Quarterly Report DocumentQuarterlyReport	true
CY2024Q3	dei	Document Period End Date DocumentPeriodEndDate	2024-09-30
CY2024Q3	dei	Document Transition Report DocumentTransitionReport	false
CY2024Q3	dei	Entity File Number EntityFileNumber	000-19333
CY2024Q3	dei	Entity Registrant Name EntityRegistrantName	Bion Environmental Technologies, Inc.
CY2024Q3	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	CO
CY2024Q3	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	84-1176672
CY2024Q3	dei	Entity Address Address Line1 EntityAddressAddressLine1	9 East Park Court
CY2024Q3	dei	Entity Address City Or Town EntityAddressCityOrTown	Old Bethpage
CY2024Q3	dei	Entity Address State Or Province EntityAddressStateOrProvince	NY
CY2024Q3	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	11804
CY2024Q3	dei	City Area Code CityAreaCode	516
CY2024Q3	dei	Local Phone Number LocalPhoneNumber	586-5643
CY2024Q3	dei	Security12b Title Security12bTitle	Common Stock
CY2024Q3	dei	Trading Symbol TradingSymbol	BNET
CY2024Q3	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2024Q3	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2024Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	52212	usd
CY2024Q2	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	16723	usd
CY2024Q2	us-gaap	Deposits Assets Current DepositsAssetsCurrent	6000	usd
CY2024Q2	us-gaap	Assets Current AssetsCurrent	74935	usd
CY2024Q2	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	36622	usd
CY2024Q2	us-gaap	Assets Assets	112252	usd
CY2024Q2	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	2703651	usd
CY2024Q2	us-gaap	Deferred Compensation Liability Current DeferredCompensationLiabilityCurrent	890223	usd
CY2024Q2	us-gaap	Convertible Notes Payable Current ConvertibleNotesPayableCurrent	1708649	usd
CY2023Q3	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	3748542	usd
CY2024Q3	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q1
CY2024Q3	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--06-30
CY2024Q2	us-gaap	Convertible Notes Payable ConvertibleNotesPayable		usd
CY2024Q3	us-gaap	Common Stock Value CommonStockValue		usd
CY2024Q2	us-gaap	Common Stock Value CommonStockValue		usd
CY2024Q3	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax		usd
CY2023Q3	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax		usd
CY2024Q3	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest		usd
CY2023Q3	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest		usd
CY2024Q3	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment		usd
CY2024Q3	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities		usd
CY2024Q3	bnet	Proceeds From Sale Of Units ProceedsFromSaleOfUnits		usd
CY2023Q3	us-gaap	Proceeds From Convertible Debt ProceedsFromConvertibleDebt		usd
CY2024Q3	us-gaap	Proceeds From Warrant Exercises ProceedsFromWarrantExercises		usd
CY2024Q3	us-gaap	Interest Paid Net InterestPaidNet		usd
CY2023Q3	us-gaap	Interest Paid Net InterestPaidNet		usd
CY2024Q3	bnet	Conversion Of Debt And Liabilities Into Common Units ConversionOfDebtAndLiabilitiesIntoCommonUnits		usd
CY2024Q3	bnet	Purchase Of Property And Equipment For Accounts Payable PurchaseOfPropertyAndEquipmentForAccountsPayable		usd
CY2024Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue		usd
CY2024Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod		shares
CY2024Q3	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
CY2024Q3	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised		shares
CY2024Q3	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
CY2024Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod		shares
CY2024Q3	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
CY2024Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod		shares
CY2024Q3	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Expirations In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice
CY2024Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue		usd
CY2024Q3	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
CY2024Q3	dei	Entity Small Business EntitySmallBusiness	true
CY2024Q3	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
CY2024Q3	dei	Entity Shell Company EntityShellCompany	false
CY2024Q4	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	56532170	shares
CY2024Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	35970	usd
CY2024Q3	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	61347	usd
CY2024Q3	us-gaap	Deposits Assets Current DepositsAssetsCurrent	6000	usd
CY2024Q3	us-gaap	Assets Current AssetsCurrent	103317	usd
CY2024Q3	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	21230	usd
CY2024Q3	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	410	usd
CY2024Q2	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	695	usd
CY2024Q3	us-gaap	Assets Assets	124957	usd
CY2024Q3	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	2770472	usd
CY2024Q3	us-gaap	Deferred Compensation Liability Current DeferredCompensationLiabilityCurrent	957311	usd
CY2024Q3	us-gaap	Convertible Notes Payable Current ConvertibleNotesPayableCurrent	1718108	usd
CY2024Q3	bnet	Convertible Bridge Note Payable Current ConvertibleBridgeNotePayableCurrent	427808	usd
CY2024Q2	bnet	Convertible Bridge Note Payable Current ConvertibleBridgeNotePayableCurrent	418659	usd
CY2024Q3	us-gaap	Convertible Notes Payable ConvertibleNotesPayable	202389	usd
CY2024Q3	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	18442	usd
CY2024Q2	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	36431	usd
CY2024Q3	us-gaap	Liabilities Current LiabilitiesCurrent	6094530	usd
CY2024Q2	us-gaap	Liabilities Current LiabilitiesCurrent	5757613	usd
CY2024Q3	us-gaap	Convertible Long Term Notes Payable ConvertibleLongTermNotesPayable	127458	usd
CY2024Q2	us-gaap	Convertible Long Term Notes Payable ConvertibleLongTermNotesPayable	125567	usd
CY2024Q3	us-gaap	Liabilities Liabilities	6221988	usd
CY2024Q2	us-gaap	Liabilities Liabilities	5883180	usd
CY2024Q3	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0
CY2024Q2	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0
CY2024Q3	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	250000000	shares
CY2024Q2	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	250000000	shares
CY2024Q3	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	57236479	shares
CY2024Q2	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	57227248	shares
CY2024Q3	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	56532170	shares
CY2024Q2	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	56522939	shares
CY2024Q3	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	134469460	usd
CY2024Q2	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	133623927	usd
CY2024Q3	us-gaap	Common Stock Share Subscribed But Unissued Subscriptions Receivable CommonStockShareSubscribedButUnissuedSubscriptionsReceivable	504650	usd
CY2024Q2	us-gaap	Common Stock Share Subscribed But Unissued Subscriptions Receivable CommonStockShareSubscribedButUnissuedSubscriptionsReceivable	504650	usd
CY2024Q3	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-140099414	usd
CY2024Q2	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-138927778	usd
CY2024Q3	us-gaap	Stockholders Equity StockholdersEquity	-6134604	usd
CY2024Q2	us-gaap	Stockholders Equity StockholdersEquity	-5808501	usd
CY2024Q3	us-gaap	Minority Interest MinorityInterest	37573	usd
CY2024Q2	us-gaap	Minority Interest MinorityInterest	37573	usd
CY2024Q3	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	-6097031	usd
CY2024Q2	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	-5770928	usd
CY2024Q3	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	124957	usd
CY2024Q2	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	112252	usd
CY2024Q3	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	959403	usd
CY2023Q3	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	666255	usd
CY2024Q3	us-gaap	Depreciation Depreciation	285	usd
CY2023Q3	us-gaap	Depreciation Depreciation	461	usd
CY2024Q3	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	6374	usd
CY2023Q3	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	8299	usd
CY2024Q3	us-gaap	Operating Expenses OperatingExpenses	966062	usd
CY2023Q3	us-gaap	Operating Expenses OperatingExpenses	675015	usd
CY2024Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	-966062	usd
CY2023Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	-675015	usd
CY2024Q3	us-gaap	Interest Income Operating InterestIncomeOperating	18	usd
CY2023Q3	us-gaap	Interest Income Operating InterestIncomeOperating	395	usd
CY2024Q3	us-gaap	Interest Expense Nonoperating InterestExpenseNonoperating	205592	usd
CY2023Q3	us-gaap	Interest Expense Nonoperating InterestExpenseNonoperating	70927	usd
CY2024Q3	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-205574	usd
CY2023Q3	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-70532	usd
CY2024Q3	us-gaap	Net Income Loss NetIncomeLoss	-1171636	usd
CY2023Q3	us-gaap	Net Income Loss NetIncomeLoss	-745547	usd
CY2024Q3	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-1171636	usd
CY2023Q3	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-745547	usd
CY2024Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.02
CY2024Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.02
CY2023Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.02
CY2023Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.02
CY2024Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	56530665	shares
CY2024Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	56530665	shares
CY2023Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	48617675	shares
CY2023Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	48617675	shares
CY2023Q2	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	4231678	usd
CY2023Q3	bnet	Sale Of Units Value SaleOfUnitsValue	45742	usd
CY2023Q3	bnet	Warrants Exercised For Common Shares WarrantsExercisedForCommonShares	28500	usd
CY2023Q3	bnet	Issuance Of Units For Services IssuanceOfUnitsForServices	27987	usd
CY2023Q3	bnet	Vesting Of Options For Employees And Services VestingOfOptionsForEmployeesAndServices	55108	usd
CY2023Q3	bnet	Vesting Of Warrants For Employees And Services VestingOfWarrantsForEmployeesAndServices	3281	usd
CY2023Q3	bnet	Debt Modification Value DebtModificationValue	-8430	usd
CY2023Q3	us-gaap	Stock Issued During Period Value Conversion Of Convertible Securities StockIssuedDuringPeriodValueConversionOfConvertibleSecurities	49048	usd
CY2023Q3	bnet	Adjustment To Additional Paid In Capital Modification Of Warrants AdjustmentToAdditionalPaidInCapitalModificationOfWarrants	61175	usd
CY2023Q3	us-gaap	Profit Loss ProfitLoss	-745547	usd
CY2024Q2	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	-5770928	usd
CY2024Q3	bnet	Issuance Of Units For Services IssuanceOfUnitsForServices	6000	usd
CY2024Q3	bnet	Adjustment To Additional Paid In Capital Modification Of Warrants AdjustmentToAdditionalPaidInCapitalModificationOfWarrants	507405	usd
CY2024Q3	bnet	Modification Of Options ModificationOfOptions	332128	usd
CY2024Q3	us-gaap	Profit Loss ProfitLoss	-1171636	usd
CY2024Q3	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	-6097031	usd
CY2024Q3	us-gaap	Net Income Loss NetIncomeLoss	-1171636	usd
CY2023Q3	us-gaap	Net Income Loss NetIncomeLoss	-745547	usd
CY2024Q3	us-gaap	Depreciation And Amortization DepreciationAndAmortization	285	usd
CY2023Q3	us-gaap	Depreciation And Amortization DepreciationAndAmortization	461	usd
CY2024Q3	us-gaap	Other Noncash Expense OtherNoncashExpense	205592	usd
CY2023Q3	us-gaap	Other Noncash Expense OtherNoncashExpense	70927	usd
CY2024Q3	us-gaap	Share Based Compensation ShareBasedCompensation	658603	usd
CY2023Q3	us-gaap	Share Based Compensation ShareBasedCompensation	58389	usd
CY2024Q3	us-gaap	Issuance Of Stock And Warrants For Services Or Claims IssuanceOfStockAndWarrantsForServicesOrClaims	6000	usd
CY2023Q3	us-gaap	Issuance Of Stock And Warrants For Services Or Claims IssuanceOfStockAndWarrantsForServicesOrClaims	27987	usd
CY2024Q3	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	44624	usd
CY2023Q3	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	-505	usd
CY2024Q3	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	66821	usd
CY2023Q3	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	-8071	usd
CY2024Q3	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	-2597	usd
CY2023Q3	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	-2596	usd
CY2024Q3	us-gaap	Increase Decrease In Deferred Compensation IncreaseDecreaseInDeferredCompensation	63750	usd
CY2023Q3	us-gaap	Increase Decrease In Deferred Compensation IncreaseDecreaseInDeferredCompensation	202500	usd
CY2024Q3	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-217806	usd
CY2023Q3	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-395445	usd
CY2023Q3	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	164408	usd
CY2023Q3	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-164408	usd
CY2023Q3	bnet	Proceeds From Sale Of Units ProceedsFromSaleOfUnits	45742	usd
CY2024Q3	us-gaap	Proceeds From Convertible Debt ProceedsFromConvertibleDebt	201564	usd
CY2023Q3	us-gaap	Proceeds From Warrant Exercises ProceedsFromWarrantExercises	28500	usd
CY2024Q3	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	201564	usd
CY2023Q3	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	74242	usd
CY2024Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	-16242	usd
CY2023Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	-485611	usd
CY2024Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	52212	usd
CY2023Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	625964	usd
CY2024Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	35970	usd
CY2023Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	140353	usd
CY2023Q3	bnet	Conversion Of Debt And Liabilities Into Common Units ConversionOfDebtAndLiabilitiesIntoCommonUnits	49048	usd
CY2023Q3	bnet	Purchase Of Property And Equipment For Accounts Payable PurchaseOfPropertyAndEquipmentForAccountsPayable	600416	usd
CY2024Q3	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	-1171600	usd
CY2024Q3	bnet	Noncash Compensation Expenses Related To Extension Of Warrants And Options NoncashCompensationExpensesRelatedToExtensionOfWarrantsAndOptions	659000	usd
CY2024	us-gaap	Asset Impairment Charges AssetImpairmentCharges	9460425	usd
CY2024	us-gaap	Stockholders Equity Other StockholdersEquityOther	5808501	usd
CY2024	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	11691115	usd
CY2024Q3	us-gaap	Cash Equivalents At Carrying Value CashEquivalentsAtCarryingValue	0	usd
CY2024Q2	us-gaap	Cash Equivalents At Carrying Value CashEquivalentsAtCarryingValue	0	usd
CY2024Q3	us-gaap	Concentration Risk Credit Risk ConcentrationRiskCreditRisk	<p id="xdx_840_eus-gaap--ConcentrationRiskCreditRisk_zeHB0qVYGX69" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b><span id="xdx_86D_zxHdcCJmaon5">Concentrations of credit risk:</span></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b> </b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company's financial instruments that are exposed to concentrations of credit risk consist of cash. The Company's cash is in demand deposit accounts placed with federally insured financial institutions and selected brokerage accounts. Such deposit accounts at times may exceed federally insured limits. The Company has not experienced any losses on such accounts.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p>
CY2024Q3	bnet	Shares Issued Beginning Of Period SharesIssuedBeginningOfPeriod	57227248	shares
CY2023Q3	bnet	Shares Issued Beginning Of Period SharesIssuedBeginningOfPeriod	48880237	shares
CY2024Q3	bnet	Shares Held By Subsidiaries SharesHeldBySubsidiaries	-704309	shares
CY2023Q3	bnet	Shares Held By Subsidiaries SharesHeldBySubsidiaries	-704309	shares
CY2024Q3	bnet	Shares Outstanding Beginning Of Period SharesOutstandingBeginningOfPeriod	56522939	shares
CY2023Q3	bnet	Shares Outstanding Beginning Of Period SharesOutstandingBeginningOfPeriod	48175928	shares
CY2024Q3	bnet	Weighted Average Shares Issued During Period WeightedAverageSharesIssuedDuringPeriod	7726	shares
CY2023Q3	bnet	Weighted Average Shares Issued During Period WeightedAverageSharesIssuedDuringPeriod	441747	shares
CY2024Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	56530665	shares
CY2023Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	48617675	shares
CY2024Q3	us-gaap	Use Of Estimates UseOfEstimates	<p id="xdx_846_eus-gaap--UseOfEstimates_zJYbIsTj45Ae" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b><span id="xdx_860_zZLhOhAc3Ei7">Use of estimates:</span></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b> </b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">In preparing the Company’s condensed consolidated financial statements in conformity with accounting principles generally accepted in the United States of America, management is required to make estimates and assumptions that affect the reported amounts of assets and liabilities and the disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b> </b></p>
CY2024Q3	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	12607	usd
CY2024Q2	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	12607	usd
CY2024Q3	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	12197	usd
CY2024Q2	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	11912	usd
CY2024Q3	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	410	usd
CY2024Q2	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	695	usd
CY2024Q3	us-gaap	Depreciation Depreciation	285	usd
CY2023Q3	us-gaap	Depreciation Depreciation	461	usd
CY2024Q3	us-gaap	Deferred Compensation Liability Current DeferredCompensationLiabilityCurrent	957311	usd
CY2024Q2	us-gaap	Deferred Compensation Liability Current DeferredCompensationLiabilityCurrent	890223	usd
CY2023Q4	bnet	Initial Tranche InitialTranche	250000	usd
CY2024Q2	bnet	Carrying Value Of Initial Project CarryingValueOfInitialProject	0	usd
CY2024	us-gaap	Asset Impairment Charges AssetImpairmentCharges	9460425	usd
CY2024	us-gaap	Stockholders Equity Other StockholdersEquityOther	5808501	usd
CY2024	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	11691115	usd
CY2024Q3	bnet	Number Of Warrants Modified NumberOfWarrantsModified	5795099	shares
CY2024Q3	bnet	Noncash Employee Compensation NoncashEmployeeCompensation	326475	usd
CY2024Q3	us-gaap	Interest Expense Other InterestExpenseOther	180929	usd
CY2024Q3	bnet	Number Of Options Modified NumberOfOptionsModified	3806600	shares
CY2024Q3	bnet	Noncash Compensation NoncashCompensation	332128	usd
CY2024Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	5001600	shares
CY2024Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	0.84
CY2024	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P0Y10M6D
CY2024Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	5001600	shares
CY2024Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	0.84
CY2024Q3	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P2Y1M9D
CY2022Q1	us-gaap	Debt Instrument Interest Rate During Period DebtInstrumentInterestRateDuringPeriod	0.25	pure
CY2022Q2	us-gaap	Debt Instrument Interest Rate During Period DebtInstrumentInterestRateDuringPeriod	0.25	pure
CY2023Q1	us-gaap	Debt Instrument Periodic Payment DebtInstrumentPeriodicPayment	533100	usd
CY2023Q2	us-gaap	Prepaid Expense And Other Assets PrepaidExpenseAndOtherAssets	83275	usd
CY2023Q2	bnet	Aggregate Payment AggregatePayment	2615500	usd
CY2023Q3	us-gaap	Debt Instrument Periodic Payment DebtInstrumentPeriodicPayment	50000	usd
CY2024Q1	us-gaap	Debt Instrument Periodic Payment DebtInstrumentPeriodicPayment	16666	usd
CY2023Q3	bnet	Final Invoice Balance FinalInvoiceBalance	33334	usd
CY2024Q3	us-gaap	Interest Costs Incurred Capitalized InterestCostsIncurredCapitalized	6794925	usd
CY2024Q3	bnet	Interest Costs Capitalized Paid InterestCostsCapitalizedPaid	7369529	usd
CY2024Q3	us-gaap	Interest Costs Capitalized Adjustment InterestCostsCapitalizedAdjustment	1681105	usd
CY2024Q3	bnet	Interests Costs Incurred Capitalized InterestsCostsIncurredCapitalized	8406434	usd
CY2024	us-gaap	Asset Impairment Charges AssetImpairmentCharges	9460425	usd
CY2024	us-gaap	Stockholders Equity Other StockholdersEquityOther	5808501	usd
CY2024	us-gaap	Net Income Loss NetIncomeLoss	-11691115	usd
CY2024Q3	bnet	Operating Leases Future Minimum Payment Receivable In Two Years OperatingLeasesFutureMinimumPaymentReceivableInTwoYears	18750	usd
CY2024Q3	bnet	Undiscounted Cash Flow UndiscountedCashFlow	18750	usd
CY2024Q3	bnet	Less Imputed Interest LessImputedInterest	-308	usd
CY2024Q3	bnet	Capital Lease Contingent Rental Payments Due CapitalLeaseContingentRentalPaymentsDue	18442	usd
CY2024Q3	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P0Y3M
CY2024Q3	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.10	pure
CY2024Q3	us-gaap	Operating Lease Payments OperatingLeasePayments	68750	usd
CY2024Q3	ecd	Rule10b51 Arr Adopted Flag Rule10b51ArrAdoptedFlag	false
CY2024Q3	ecd	Non Rule10b51 Arr Adopted Flag NonRule10b51ArrAdoptedFlag	false
CY2024Q3	ecd	Rule10b51 Arr Trmntd Flag Rule10b51ArrTrmntdFlag	false
CY2024Q3	ecd	Non Rule10b51 Arr Trmntd Flag NonRule10b51ArrTrmntdFlag	false

Files In Submission

Name	View Source	Status
bnet-20240930_cal.xml	Edgar Link	unprocessable
0001079973-24-001553-index-headers.html	Edgar Link	pending
0001079973-24-001553-index.html	Edgar Link	pending
0001079973-24-001553.txt	Edgar Link	pending
0001079973-24-001553-xbrl.zip	Edgar Link	pending
bion_10q-093024.htm	Edgar Link	pending
bion_ex31x1.htm	Edgar Link	pending
bion_ex32x1.htm	Edgar Link	pending
bnet-20240930.xsd	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
bnet-20240930_def.xml	Edgar Link	unprocessable
bnet-20240930_lab.xml	Edgar Link	unprocessable
bnet-20240930_pre.xml	Edgar Link	unprocessable
FilingSummary.xml	Edgar Link	unprocessable
bion_10q-093024_htm.xml	Edgar Link	completed
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$BNET
BION ENVIRONMENTAL TECHNOLOGIES INC Stock $bnet

2024 Q4 Form 10-Q Financial Statement

#000107997324001553 Filed on November 14, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$BNET BION ENVIRONMENTAL TECHNOLOGIES INC Stock $bnet

2024 Q4 Form 10-Q Financial Statement

#000107997324001553 Filed on November 14, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$BNET
BION ENVIRONMENTAL TECHNOLOGIES INC Stock $bnet